Advertisement

Bleeding and Thrombosis in Cancer Patients

  • Joseph ShatzelEmail author
Chapter

Abstract

This chapter focuses on bleeding and thrombotic issues in patients with cancer. Different bleeding disorders associated with cancer are discussed as well as treatment. Risk factors for cancer-related thrombosis and treatments are discussed as well.

Keyword

Acute promyelocytic leukemia Thalidomide L-asparaginase stem cell transplantation Myeloma Ibrutinib 

Suggested Reading

  1. Barbui T, Finazzi G, Falanga A. Myeloproliferative neoplasms and thrombosis. Blood. 2013;122(13):2176–84.CrossRefGoogle Scholar
  2. Choudhry A, DeLoughery TG. Bleeding and thrombosis in acute promyelocytic leukemia. Am J Hematol. 2012;87(6):596–603.CrossRefGoogle Scholar
  3. Kraaijpoel N, Carrier M. How I treat cancer-associated venous thromboembolism. Blood. 2019;133(4):291–8.CrossRefGoogle Scholar
  4. Leebeek FW. Update of thrombosis in multiple myeloma. Thromb Res. 2016;140(Suppl 1):S76–80.CrossRefGoogle Scholar
  5. Patel HK, Khorana AA. Anticoagulation in cancer patients: a summary of pitfalls to avoid. Curr Oncol Rep. 2019;21(2):18.CrossRefGoogle Scholar
  6. Patriquin CJ, Kiss T, Caplan S, Chin-Yee I, Grewal K, Grossman J, Larratt L, Marceau D, Nevill T, Sutherland DR, Wells RA, Leber B. How we treat paroxysmal nocturnal hemoglobinuria: a consensus statement of the Canadian PNH Network and review of the national registry. Eur J Haematol. 2019;102(1):36–52.CrossRefGoogle Scholar
  7. Shatzel J, Scherber R, DeLoughery TG. Bleeding and thrombosis in hematologic neoplasia. In: Neoplastic diseases of the blood. Switzerland: Springer; 2018. p. 1263–89.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Division of Hematology/Medical Oncology, Department of Medicine and Biomedical EngineeringOregon Health & Sciences UniversityPortlandUSA

Personalised recommendations